Angiotensin II receptor antagonist valsartan in treatment of patients with arterial hypertension and chronic kidney diseases. Hypotensive and nephroprotective efficacy

Angiotensin II receptor blockers are highly effective and safe drugs that reduce the activity of RAAS. Valsartan is a quality, efficient antihypertensive drug with good tolerability. The effectiveness of valsartan is a combination of hemodynamic, neurohumoral, and metabolic effects, providing a posi...

Full description

Bibliographic Details
Published in:	RUDN Journal of Medicine
Main Authors:	M L Maximov, O V Dralova
Format:	Article
Language:	English
Published:	Peoples’ Friendship University of Russia (RUDN University) 2010-09-01
Subjects:	валсартан БРА артериальная гипертония хроническая болезнь почек нефропротекция
Online Access:	http://journals.rudn.ru/medicine/article/view/3545

Similar Items

Clinical efficiency of medium and high doses of valsartan in the treatment of patient with arterial hypertension and chronic kidney diseases
by: M L Maximov, et al.
Published: (2010-12-01)

Артериальная гипертензия и заболевания почек: фактор врача и фактор социума
Published: (2018-06-01)

ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION OF VALSARTAN AND VALSARTAN AND HYDROCHLOROTHIAZIDE COMBINATION IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

CHANGES IN THE PARAMETERS OF 24-HOUR BLOOD PRESSURE MONITORING AND ARTERIAL STIFFNESS IN PATIENTS WITH HYPERTENSION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATED WITH VALSARTAN
by: N. A. Karoli, et al.
Published: (2015-09-01)

Clinical application of direct renin inhibitor aliskiren in combined therapy of patients with arterial hypertension and metabolic syndrome
by: O V Dralova, et al.
Published: (2010-12-01)

ARTERIAL STIFFNESS AND CHRONIC KIDNEY DISEASE: CAUSES AND CONSEQUENCES
by: J. D. Kobalava, et al.
Published: (2015-09-01)

EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK
by: I. M. Sokolov, et al.
Published: (2015-12-01)

Immunological aspects of the development of hypertension and renal dysfunction in patients with chronic diseases of joints
by: A V Safronenko, et al.
Published: (2012-09-01)

THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

FEATURES OF THE PSYCHOLOGICAL PROFILE OF PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE IN THE CONDITIONS OF COMORBIDITY
by: Evgeny Vyacheslavovich Kozlov, et al.
Published: (2019-07-01)

CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION
by: V. N. Shishkova
Published: (2015-09-01)

A PATIENT WITH CHRONIC HEMODIALYSIS WITH COMORBID ONCOLOGICAL PATHOLOGY – A SERIES OF CLINICAL CASES
by: Александр Анатольевич Шапкин, et al.
Published: (2020-09-01)

CHANGES OF INTERCELLULAR COOPERATION IN PERIPHERAL BLOOD IN TREATED PATIENTS WITH CARDIOLOGIC DISEASES
by: L. N. Korichkina, et al.
Published: (2016-01-01)

FEATURES OF INDICATORS OF DAILY MONITORING OF ARTERIAL PRESSURE IN MEN WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE CONTEXT OF COMORBIDITY
by: Evgeny Vyacheslavovich Kozlov, et al.
Published: (2019-05-01)

EXPERIENCE OF TREATMENT OF PATIENTS WITH CHRONIC KIDNEY DISEASE USING THE METHOD OF PERITONEAL DIALYSIS
by: Татьяна Владимировна Мироненко, et al.
Published: (2021-11-01)

Нефармакологические нефропротективные стратегии в сочетании с доставкой оксида азота у кардиохирургических пациентов с хронической болезнью почек
by: М.А. Тё, et al.
Published: (2024-12-01)

FEMALE SEX HORMONES AS MODULATORS OF GENDER DIFFERENCES IN RESPONSE TO PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES
by: S. N. Tereshchenko, et al.
Published: (2015-12-01)

ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION
by: N. A. Dzhaiani
Published: (2015-09-01)

ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2015-09-01)

BISOPROLOL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH CARDIOPULMONARY DISEASES
by: G. N. Gorokchovskaya, et al.
Published: (2016-01-01)

ДИСФУНКЦИЯ ПОЧЕК КАК ПРЕДИКТОР ПРОГРЕССИРОВАНИЯ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ
by: О. В. Заблоцкая, et al.
Published: (2023-09-01)

IEFFICACY OF INDAPAMIDE AND VALSARTAN COMBINED THERAPY PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC DISORDERS
by: G. A. Khamidullaeva, et al.
Published: (2014-12-01)

BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE
by: M. V. Leonova
Published: (2015-12-01)

РОЛЬ БЕЛКА КЛОТО В ПАТОГЕНЕЗЕ НЕКОТОРЫХ ЗАБОЛЕВАНИЙ. ОБЗОР ЛИТЕРАТУРЫ
by: Татьяна Вячеславовна Чивиргина, et al.
Published: (2025-04-01)

DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE
by: S. Y. Martsevich
Published: (2015-12-01)

Периоперационное кондиционирование оксидом азота для предотвращения острого почечного повреждения при кардиохирургических вмешательствах у пациентов с хронической болезнью почек: промежуточные результаты рандомизированного контролируемого исследования DEF
by: Николай Олегович Каменщиков, et al.
Published: (2024-11-01)

SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)
by: R. Eschalier, et al.
Published: (2015-09-01)

ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION
by: M. V. Leonova, et al.
Published: (2015-12-01)

NEW ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE
by: E. P. Panchenko
Published: (2015-12-01)

RESISTANT ARTERIAL HYPERTENSION: IS THE CONSENSUS BETWEEN CONSERVATIVE AND INTERVENTIONAL THERAPY POSSIBLE?
by: Yu. I. Grinshtein, et al.
Published: (2015-09-01)

Circadian blood pressure profile in patients with arterial hypertension and chronic obstructive pulmonary disease
by: T. E. Steshina, et al.
Published: (2005-08-01)

Study of the features of microvasculature in patients with arterial hypertension and end-organ damage
by: L. A. Khaisheva, et al.
Published: (2014-08-01)

Анализ медицинской технологии коррекции гиперфосфатемии при хронической болезни почек
Published: (2018-06-01)

Современный взгляд на лечение анемии у больных с диабетическим поражением почек
Published: (2016-12-01)

EXPERIENCE IN THE USE OF BISOPROLOL IN THE TREATMENT OF OUTPATIENT HYPERTENSIVE PATIENTS AFTER STROKE
by: I. I. Esenova, et al.
Published: (2015-09-01)

Primenenie Preduktala pri lechenii bol'nykh arterial'noy gipertoniey i ishemicheskoy bolezn'yu serdtsa, assotsiirovannykh s sakharnym diabetom 2 tipa
by: R S Karpov, et al.
Published: (2006-03-01)

ДИАГНОСТИКА КАРДИАЛЬНОГО ФИБРОЗА ПЕЧЕНИ НЕИНВАЗИВНЫМИ МЕТОДАМИ У БОЛЬНЫХ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ И ХРОНИЧЕСКОЙ БОЛЕЗНЬЮ ПОЧЕК
by: К.А. Кислюк, et al.
Published: (2023-12-01)

ВЛИЯНИЕ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК НА ПОЛОВУЮ ФУНКЦИЮ У ЖЕНЩИН
by: E. G. Sazonova, et al.
Published: (2016-09-01)

ASSESSMENT OF PULMONARY HYPERTENSION BY ECHOCARDIOGRAPHY IN PATIENTS WITH PREDIALYSIS STAGE OF CHRONIC KIDNEY DISEASE
by: M. P. Vasilyeva, et al.
Published: (2016-02-01)

REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS
by: M. N. Mamedov, et al.
Published: (2015-12-01)